Atul Varadhachary

Atul Varadhachary currently works at Radiomer Therapeutics, Inc., as Chief Executive Officer from 2024, Allterum Therapeutics, Inc., as Executive Chairman, BioHouston, Inc., as Member Board of Directors from 2018, The Indus Entrepreneurs, as Director from 2021, Pulmotect, Inc., as Director, Fannin Partners LLC, as MANAGING PARTNER from 2013, and Goldenrod Therapeutics, Inc., as President.
Dr. Varadhachary also formerly worked at Harris County Hospital District (Texas), as Director, Every Texan, as Member Board of Directors from 2013 to 2023, McKinsey & Co., Inc., as Senior Engagement Manager, William Marsh Rice University, as Adjunct Professor, Agennix, Inc., as President & Chief Operating Officer from 2001 to 2009, Baylor College of Medicine, as Adjunct Professor, Reliance Life Sciences Pvt Ltd., as President & U.S.
Operations from 2011 to 2013, and Pratham USA, as President.
Dr. Varadhachary received his doctorate degree from The Johns Hopkins University and doctorate degree from the University of Mumbai.